Topline: Oral Semaglutide Cuts Cardiovascular Events in T2D ...Middle East

In Novo Nordisk’s randomized clinical trial, semaglutide reduced the risk for major adverse cardiovascular events by 14% compared with placebo. Medscape Medical News

Hence then, the article about topline oral semaglutide cuts cardiovascular events in t2d was published today ( Tuesday 22/10/2024 - 03:41 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Topline: Oral Semaglutide Cuts Cardiovascular Events in T2D )

Also on site :

• Not to be dramatic, but LEGO Batman: Legacy of the Dark Knight might be the best Batman game ever
• Iran war day 68: Trump talks about progress in talks; Rubio says war ‘over’
• US greenlights bomb deal for Ukraine